nodes	percent_of_prediction	percent_of_DWPC	metapath
Glucosamine—TNF—Alzheimer's disease	0.62	1	CbGaD
Glucosamine—CYP2C19—Memantine—Alzheimer's disease	0.0593	1	CbGbCtD
Glucosamine—IFNG—blood vessel—Alzheimer's disease	0.00894	0.253	CbGeAlD
Glucosamine—MMP9—blood vessel—Alzheimer's disease	0.00574	0.162	CbGeAlD
Glucosamine—MMP9—embryo—Alzheimer's disease	0.00342	0.0968	CbGeAlD
Glucosamine—NFKB2—brain—Alzheimer's disease	0.00289	0.0816	CbGeAlD
Glucosamine—IFNG—nervous system—Alzheimer's disease	0.00256	0.0724	CbGeAlD
Glucosamine—IFNG—central nervous system—Alzheimer's disease	0.00246	0.0697	CbGeAlD
Glucosamine—IFNG—brain—Alzheimer's disease	0.00196	0.0553	CbGeAlD
Glucosamine—MMP9—nervous system—Alzheimer's disease	0.00164	0.0465	CbGeAlD
Glucosamine—MMP9—central nervous system—Alzheimer's disease	0.00158	0.0448	CbGeAlD
Glucosamine—MMP9—brain—Alzheimer's disease	0.00126	0.0355	CbGeAlD
Glucosamine—CYP2E1—telencephalon—Alzheimer's disease	0.000917	0.0259	CbGeAlD
Glucosamine—CYP2E1—nervous system—Alzheimer's disease	0.000541	0.0153	CbGeAlD
Glucosamine—CYP2E1—central nervous system—Alzheimer's disease	0.000521	0.0147	CbGeAlD
Glucosamine—CYP2E1—cerebellum—Alzheimer's disease	0.000509	0.0144	CbGeAlD
Glucosamine—CYP2E1—brain—Alzheimer's disease	0.000414	0.0117	CbGeAlD
Glucosamine—MMP9—Spinal Cord Injury—IL6—Alzheimer's disease	5.41e-05	0.000189	CbGpPWpGaD
Glucosamine—IFNG—Immune System—GAB2—Alzheimer's disease	5.34e-05	0.000187	CbGpPWpGaD
Glucosamine—IFNG—Immune System—GSK3A—Alzheimer's disease	5.29e-05	0.000185	CbGpPWpGaD
Glucosamine—TNF—Folate Metabolism—IL6—Alzheimer's disease	5.27e-05	0.000185	CbGpPWpGaD
Glucosamine—CYP2C19—Biological oxidations—PTGS1—Alzheimer's disease	5.27e-05	0.000185	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—S100B—Alzheimer's disease	5.22e-05	0.000183	CbGpPWpGaD
Glucosamine—IFNG—Immune System—APP—Alzheimer's disease	5.2e-05	0.000182	CbGpPWpGaD
Glucosamine—TNF—Integrated Pancreatic Cancer Pathway—CREB1—Alzheimer's disease	5.19e-05	0.000182	CbGpPWpGaD
Glucosamine—CYP2C19—Biological oxidations—CYP2D6—Alzheimer's disease	5.17e-05	0.000181	CbGpPWpGaD
Glucosamine—TNF—Apoptosis—BCL2—Alzheimer's disease	5.15e-05	0.00018	CbGpPWpGaD
Glucosamine—CYP2C19—Metapathway biotransformation—CYP2D6—Alzheimer's disease	5.1e-05	0.000179	CbGpPWpGaD
Glucosamine—TNF—Alzheimers Disease—TP53—Alzheimer's disease	4.99e-05	0.000175	CbGpPWpGaD
Glucosamine—TNF—Integrated Pancreatic Cancer Pathway—IGF1—Alzheimer's disease	4.99e-05	0.000175	CbGpPWpGaD
Glucosamine—TNF—Regulation of toll-like receptor signaling pathway—IL1B—Alzheimer's disease	4.96e-05	0.000174	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism of lipids and lipoproteins—PLD3—Alzheimer's disease	4.85e-05	0.00017	CbGpPWpGaD
Glucosamine—MMP9—Extracellular matrix organization—CASP3—Alzheimer's disease	4.84e-05	0.000169	CbGpPWpGaD
Glucosamine—NFKB2—Innate Immune System—BCL2—Alzheimer's disease	4.78e-05	0.000167	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—CDK5—Alzheimer's disease	4.77e-05	0.000167	CbGpPWpGaD
Glucosamine—TNF—Apoptosis—TP53—Alzheimer's disease	4.75e-05	0.000166	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—IL1A—Alzheimer's disease	4.72e-05	0.000165	CbGpPWpGaD
Glucosamine—MMP9—Signaling by SCF-KIT—IL6—Alzheimer's disease	4.69e-05	0.000164	CbGpPWpGaD
Glucosamine—MMP9—Developmental Biology—LEP—Alzheimer's disease	4.61e-05	0.000161	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—HTR6—Alzheimer's disease	4.6e-05	0.000161	CbGpPWpGaD
Glucosamine—TNF—Developmental Biology—DLG4—Alzheimer's disease	4.58e-05	0.00016	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—MEF2C—Alzheimer's disease	4.57e-05	0.00016	CbGpPWpGaD
Glucosamine—TNF—Regulation of toll-like receptor signaling pathway—MAPK8—Alzheimer's disease	4.55e-05	0.000159	CbGpPWpGaD
Glucosamine—TNF—Apoptosis—CASP3—Alzheimer's disease	4.54e-05	0.000159	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—AGER—Alzheimer's disease	4.53e-05	0.000158	CbGpPWpGaD
Glucosamine—TNF—SIDS Susceptibility Pathways—IL1B—Alzheimer's disease	4.53e-05	0.000158	CbGpPWpGaD
Glucosamine—TNF—SIDS Susceptibility Pathways—CASP3—Alzheimer's disease	4.52e-05	0.000158	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—PRKCG—Alzheimer's disease	4.48e-05	0.000157	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism of lipids and lipoproteins—CYP46A1—Alzheimer's disease	4.48e-05	0.000157	CbGpPWpGaD
Glucosamine—TNF—Developmental Biology—GRIN2B—Alzheimer's disease	4.48e-05	0.000157	CbGpPWpGaD
Glucosamine—NFKB2—Cytokine Signaling in Immune system—IL6—Alzheimer's disease	4.42e-05	0.000155	CbGpPWpGaD
Glucosamine—TNF—Spinal Cord Injury—TGFB1—Alzheimer's disease	4.4e-05	0.000154	CbGpPWpGaD
Glucosamine—TNF—Integrated Pancreatic Cancer Pathway—BCL2—Alzheimer's disease	4.36e-05	0.000152	CbGpPWpGaD
Glucosamine—MMP9—Signaling by SCF-KIT—AKT1—Alzheimer's disease	4.33e-05	0.000152	CbGpPWpGaD
Glucosamine—TNF—MAPK Signaling Pathway—IL1B—Alzheimer's disease	4.27e-05	0.000149	CbGpPWpGaD
Glucosamine—TNF—MAPK Signaling Pathway—CASP3—Alzheimer's disease	4.26e-05	0.000149	CbGpPWpGaD
Glucosamine—MMP9—Developmental Biology—NOTCH1—Alzheimer's disease	4.26e-05	0.000149	CbGpPWpGaD
Glucosamine—IFNG—Immune System—S100B—Alzheimer's disease	4.23e-05	0.000148	CbGpPWpGaD
Glucosamine—TNF—Selenium Micronutrient Network—IL6—Alzheimer's disease	4.19e-05	0.000147	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—PSENEN—Alzheimer's disease	4.17e-05	0.000146	CbGpPWpGaD
Glucosamine—TNF—Apoptosis—MAPK8—Alzheimer's disease	4.17e-05	0.000146	CbGpPWpGaD
Glucosamine—TNF—Integrated Pancreatic Cancer Pathway—PTGS2—Alzheimer's disease	4.14e-05	0.000145	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—APH1A—Alzheimer's disease	4.11e-05	0.000144	CbGpPWpGaD
Glucosamine—TNF—Adipogenesis—TGFB1—Alzheimer's disease	4.07e-05	0.000142	CbGpPWpGaD
Glucosamine—TNF—TNF alpha Signaling Pathway—IL6—Alzheimer's disease	4.04e-05	0.000142	CbGpPWpGaD
Glucosamine—TNF—Developmental Biology—ADAM10—Alzheimer's disease	4.04e-05	0.000141	CbGpPWpGaD
Glucosamine—MMP9—Developmental Biology—PPARG—Alzheimer's disease	4.02e-05	0.000141	CbGpPWpGaD
Glucosamine—TNF—Apoptosis—AKT1—Alzheimer's disease	4.01e-05	0.00014	CbGpPWpGaD
Glucosamine—TNF—MicroRNAs in cardiomyocyte hypertrophy—AKT1—Alzheimer's disease	4.01e-05	0.00014	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—NCSTN—Alzheimer's disease	4.01e-05	0.00014	CbGpPWpGaD
Glucosamine—MMP9—Developmental Biology—GSK3B—Alzheimer's disease	3.99e-05	0.00014	CbGpPWpGaD
Glucosamine—MMP9—Developmental Biology—CREB1—Alzheimer's disease	3.96e-05	0.000139	CbGpPWpGaD
Glucosamine—MMP9—Developmental Biology—INS—Alzheimer's disease	3.94e-05	0.000138	CbGpPWpGaD
Glucosamine—TNF—MAPK Signaling Pathway—MAPK8—Alzheimer's disease	3.91e-05	0.000137	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—LRP1—Alzheimer's disease	3.91e-05	0.000137	CbGpPWpGaD
Glucosamine—NFKB2—Innate Immune System—MAPK8—Alzheimer's disease	3.88e-05	0.000136	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—CALM1—Alzheimer's disease	3.88e-05	0.000136	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—DHCR24—Alzheimer's disease	3.87e-05	0.000136	CbGpPWpGaD
Glucosamine—TNF—Integrated Pancreatic Cancer Pathway—CASP3—Alzheimer's disease	3.84e-05	0.000134	CbGpPWpGaD
Glucosamine—TNF—SIDS Susceptibility Pathways—VEGFA—Alzheimer's disease	3.83e-05	0.000134	CbGpPWpGaD
Glucosamine—IFNG—Immune System—IL1A—Alzheimer's disease	3.83e-05	0.000134	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—GFAP—Alzheimer's disease	3.82e-05	0.000134	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—GAL—Alzheimer's disease	3.82e-05	0.000134	CbGpPWpGaD
Glucosamine—MMP9—Extracellular matrix organization—TGFB1—Alzheimer's disease	3.77e-05	0.000132	CbGpPWpGaD
Glucosamine—TNF—TNF alpha Signaling Pathway—AKT1—Alzheimer's disease	3.73e-05	0.000131	CbGpPWpGaD
Glucosamine—TNF—Toll-like Receptor Signaling Pathway—IL6—Alzheimer's disease	3.72e-05	0.00013	CbGpPWpGaD
Glucosamine—IFNG—Immune System—MEF2C—Alzheimer's disease	3.7e-05	0.00013	CbGpPWpGaD
Glucosamine—TNF—Developmental Biology—PPARGC1A—Alzheimer's disease	3.7e-05	0.00013	CbGpPWpGaD
Glucosamine—IFNG—Immune System—AGER—Alzheimer's disease	3.67e-05	0.000128	CbGpPWpGaD
Glucosamine—IFNG—Immune System—PRKCG—Alzheimer's disease	3.63e-05	0.000127	CbGpPWpGaD
Glucosamine—TNF—Spinal Cord Injury—TP53—Alzheimer's disease	3.62e-05	0.000127	CbGpPWpGaD
Glucosamine—IFNG—Cytokine Signaling in Immune system—IL6—Alzheimer's disease	3.58e-05	0.000125	CbGpPWpGaD
Glucosamine—TNF—Integrated Pancreatic Cancer Pathway—MAPK8—Alzheimer's disease	3.53e-05	0.000124	CbGpPWpGaD
Glucosamine—MMP9—Axon guidance—VEGFA—Alzheimer's disease	3.49e-05	0.000122	CbGpPWpGaD
Glucosamine—TNF—Toll-like Receptor Signaling Pathway—AKT1—Alzheimer's disease	3.43e-05	0.00012	CbGpPWpGaD
Glucosamine—TNF—Developmental Biology—LPL—Alzheimer's disease	3.37e-05	0.000118	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—A2M—Alzheimer's disease	3.36e-05	0.000118	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—GSK3B—Alzheimer's disease	3.35e-05	0.000117	CbGpPWpGaD
Glucosamine—TNF—Developmental Biology—MEF2C—Alzheimer's disease	3.34e-05	0.000117	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—CREB1—Alzheimer's disease	3.32e-05	0.000116	CbGpPWpGaD
Glucosamine—TNF—MAPK Signaling Pathway—TGFB1—Alzheimer's disease	3.31e-05	0.000116	CbGpPWpGaD
Glucosamine—TNF—Spinal Cord Injury—IL6—Alzheimer's disease	3.31e-05	0.000116	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—CA4—Alzheimer's disease	3.29e-05	0.000115	CbGpPWpGaD
Glucosamine—TNF—Integrated Pancreatic Cancer Pathway—VEGFA—Alzheimer's disease	3.26e-05	0.000114	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—PSEN2—Alzheimer's disease	3.26e-05	0.000114	CbGpPWpGaD
Glucosamine—IFNG—Immune System—CALM1—Alzheimer's disease	3.14e-05	0.00011	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—GAPDHS—Alzheimer's disease	3.1e-05	0.000108	CbGpPWpGaD
Glucosamine—TNF—Adipogenesis—IL6—Alzheimer's disease	3.07e-05	0.000107	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—NPY—Alzheimer's disease	3e-05	0.000105	CbGpPWpGaD
Glucosamine—TNF—Integrated Pancreatic Cancer Pathway—TGFB1—Alzheimer's disease	2.99e-05	0.000105	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—DHCR24—Alzheimer's disease	2.99e-05	0.000105	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—IAPP—Alzheimer's disease	2.98e-05	0.000104	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—ATP5A1—Alzheimer's disease	2.94e-05	0.000103	CbGpPWpGaD
Glucosamine—TNF—Apoptosis—TP53—Alzheimer's disease	2.91e-05	0.000102	CbGpPWpGaD
Glucosamine—TNF—Regulation of toll-like receptor signaling pathway—IL6—Alzheimer's disease	2.91e-05	0.000102	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—CRH—Alzheimer's disease	2.89e-05	0.000101	CbGpPWpGaD
Glucosamine—TNF—Developmental Biology—LEP—Alzheimer's disease	2.82e-05	9.88e-05	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—PLD3—Alzheimer's disease	2.8e-05	9.81e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism of lipids and lipoproteins—CHAT—Alzheimer's disease	2.79e-05	9.76e-05	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—BCL2—Alzheimer's disease	2.79e-05	9.75e-05	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—NPS—Alzheimer's disease	2.74e-05	9.6e-05	CbGpPWpGaD
Glucosamine—TNF—MAPK Signaling Pathway—TP53—Alzheimer's disease	2.73e-05	9.55e-05	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—PPP3CA—Alzheimer's disease	2.73e-05	9.55e-05	CbGpPWpGaD
Glucosamine—IFNG—Immune System—GSK3B—Alzheimer's disease	2.71e-05	9.49e-05	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—PTK2B—Alzheimer's disease	2.69e-05	9.41e-05	CbGpPWpGaD
Glucosamine—IFNG—Immune System—CREB1—Alzheimer's disease	2.69e-05	9.41e-05	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—HSD17B10—Alzheimer's disease	2.69e-05	9.4e-05	CbGpPWpGaD
Glucosamine—TNF—Regulation of toll-like receptor signaling pathway—AKT1—Alzheimer's disease	2.68e-05	9.39e-05	CbGpPWpGaD
Glucosamine—TNF—SIDS Susceptibility Pathways—IL6—Alzheimer's disease	2.65e-05	9.28e-05	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—NTRK2—Alzheimer's disease	2.62e-05	9.16e-05	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—SST—Alzheimer's disease	2.62e-05	9.16e-05	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—GAB2—Alzheimer's disease	2.62e-05	9.16e-05	CbGpPWpGaD
Glucosamine—TNF—Developmental Biology—NOTCH1—Alzheimer's disease	2.61e-05	9.12e-05	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—GSK3A—Alzheimer's disease	2.59e-05	9.08e-05	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—CYP46A1—Alzheimer's disease	2.59e-05	9.05e-05	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—APP—Alzheimer's disease	2.55e-05	8.92e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—CA4—Alzheimer's disease	2.54e-05	8.9e-05	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—ND1—Alzheimer's disease	2.5e-05	8.74e-05	CbGpPWpGaD
Glucosamine—MMP9—Developmental Biology—VEGFA—Alzheimer's disease	2.49e-05	8.71e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism of lipids and lipoproteins—A2M—Alzheimer's disease	2.48e-05	8.7e-05	CbGpPWpGaD
Glucosamine—NFKB2—Innate Immune System—IL6—Alzheimer's disease	2.48e-05	8.67e-05	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—IL1B—Alzheimer's disease	2.46e-05	8.62e-05	CbGpPWpGaD
Glucosamine—TNF—Integrated Pancreatic Cancer Pathway—TP53—Alzheimer's disease	2.46e-05	8.62e-05	CbGpPWpGaD
Glucosamine—TNF—Developmental Biology—PPARG—Alzheimer's disease	2.46e-05	8.61e-05	CbGpPWpGaD
Glucosamine—TNF—Apoptosis—AKT1—Alzheimer's disease	2.46e-05	8.6e-05	CbGpPWpGaD
Glucosamine—TNF—Developmental Biology—GSK3B—Alzheimer's disease	2.45e-05	8.56e-05	CbGpPWpGaD
Glucosamine—TNF—Developmental Biology—CREB1—Alzheimer's disease	2.43e-05	8.49e-05	CbGpPWpGaD
Glucosamine—MMP9—Axon guidance—IL6—Alzheimer's disease	2.41e-05	8.44e-05	CbGpPWpGaD
Glucosamine—TNF—Developmental Biology—INS—Alzheimer's disease	2.41e-05	8.44e-05	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—PLCB1—Alzheimer's disease	2.41e-05	8.42e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—GAPDHS—Alzheimer's disease	2.39e-05	8.37e-05	CbGpPWpGaD
Glucosamine—TNF—MAPK Signaling Pathway—AKT1—Alzheimer's disease	2.3e-05	8.07e-05	CbGpPWpGaD
Glucosamine—MMP9—Developmental Biology—TGFB1—Alzheimer's disease	2.28e-05	8e-05	CbGpPWpGaD
Glucosamine—NFKB2—Innate Immune System—AKT1—Alzheimer's disease	2.28e-05	8e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—ATP5A1—Alzheimer's disease	2.27e-05	7.93e-05	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—MAPK8—Alzheimer's disease	2.26e-05	7.91e-05	CbGpPWpGaD
Glucosamine—IFNG—Immune System—BCL2—Alzheimer's disease	2.26e-05	7.9e-05	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—NGFR—Alzheimer's disease	2.24e-05	7.86e-05	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—ADAM10—Alzheimer's disease	2.19e-05	7.67e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—PLD3—Alzheimer's disease	2.16e-05	7.57e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism of lipids and lipoproteins—ACHE—Alzheimer's disease	2.16e-05	7.57e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism of lipids and lipoproteins—INPP5D—Alzheimer's disease	2.14e-05	7.48e-05	CbGpPWpGaD
Glucosamine—MMP9—Developmental Biology—TNF—Alzheimer's disease	2.13e-05	7.47e-05	CbGpPWpGaD
Glucosamine—TNF—Integrated Pancreatic Cancer Pathway—AKT1—Alzheimer's disease	2.08e-05	7.28e-05	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—S100B—Alzheimer's disease	2.07e-05	7.26e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—HSD17B10—Alzheimer's disease	2.07e-05	7.25e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS1—Alzheimer's disease	2.03e-05	7.09e-05	CbGpPWpGaD
Glucosamine—IFNG—Immune System—IL1B—Alzheimer's disease	2e-05	6.98e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—CYP46A1—Alzheimer's disease	1.99e-05	6.98e-05	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—IGF2—Alzheimer's disease	1.97e-05	6.91e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—ND1—Alzheimer's disease	1.93e-05	6.74e-05	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—IGF1R—Alzheimer's disease	1.91e-05	6.68e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—Alzheimer's disease	1.88e-05	6.59e-05	CbGpPWpGaD
Glucosamine—IFNG—Immune System—MAPK8—Alzheimer's disease	1.83e-05	6.4e-05	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—LPL—Alzheimer's disease	1.83e-05	6.4e-05	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—MEF2C—Alzheimer's disease	1.81e-05	6.35e-05	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—PRKCG—Alzheimer's disease	1.78e-05	6.23e-05	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—NGF—Alzheimer's disease	1.73e-05	6.07e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism of lipids and lipoproteins—ABCA1—Alzheimer's disease	1.72e-05	6.03e-05	CbGpPWpGaD
Glucosamine—MMP9—Developmental Biology—IL6—Alzheimer's disease	1.72e-05	6.03e-05	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—CCR5—Alzheimer's disease	1.69e-05	5.9e-05	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—HTR2A—Alzheimer's disease	1.65e-05	5.77e-05	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—TPI1—Alzheimer's disease	1.61e-05	5.63e-05	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—CHAT—Alzheimer's disease	1.61e-05	5.63e-05	CbGpPWpGaD
Glucosamine—MMP9—Developmental Biology—AKT1—Alzheimer's disease	1.59e-05	5.56e-05	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—MAOB—Alzheimer's disease	1.54e-05	5.4e-05	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—CALM1—Alzheimer's disease	1.54e-05	5.39e-05	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—APOE—Alzheimer's disease	1.53e-05	5.37e-05	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—LEP—Alzheimer's disease	1.53e-05	5.37e-05	CbGpPWpGaD
Glucosamine—TNF—Developmental Biology—VEGFA—Alzheimer's disease	1.52e-05	5.33e-05	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—CAV1—Alzheimer's disease	1.52e-05	5.32e-05	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—GAPDH—Alzheimer's disease	1.48e-05	5.2e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism of lipids and lipoproteins—PPARGC1A—Alzheimer's disease	1.48e-05	5.2e-05	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—ESR1—Alzheimer's disease	1.46e-05	5.13e-05	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—F2—Alzheimer's disease	1.45e-05	5.06e-05	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—IL6—Alzheimer's disease	1.44e-05	5.05e-05	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—A2M—Alzheimer's disease	1.43e-05	5.02e-05	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—NOTCH1—Alzheimer's disease	1.42e-05	4.95e-05	CbGpPWpGaD
Glucosamine—TNF—Developmental Biology—TGFB1—Alzheimer's disease	1.4e-05	4.9e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism of lipids and lipoproteins—LPL—Alzheimer's disease	1.35e-05	4.73e-05	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—AKT1—Alzheimer's disease	1.33e-05	4.66e-05	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—GSK3B—Alzheimer's disease	1.33e-05	4.65e-05	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—CREB1—Alzheimer's disease	1.32e-05	4.61e-05	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—INS—Alzheimer's disease	1.31e-05	4.59e-05	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—CCL2—Alzheimer's disease	1.29e-05	4.51e-05	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—IGF1—Alzheimer's disease	1.27e-05	4.44e-05	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—ACHE—Alzheimer's disease	1.25e-05	4.37e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—CHAT—Alzheimer's disease	1.24e-05	4.35e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—TPI1—Alzheimer's disease	1.24e-05	4.35e-05	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—INPP5D—Alzheimer's disease	1.23e-05	4.32e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—MAOB—Alzheimer's disease	1.19e-05	4.17e-05	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—ENO1—Alzheimer's disease	1.17e-05	4.09e-05	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—PTGS1—Alzheimer's disease	1.17e-05	4.09e-05	CbGpPWpGaD
Glucosamine—IFNG—Immune System—IL6—Alzheimer's disease	1.17e-05	4.09e-05	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—NOS3—Alzheimer's disease	1.15e-05	4.02e-05	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—CYP2D6—Alzheimer's disease	1.15e-05	4.01e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—GAPDH—Alzheimer's disease	1.15e-05	4.01e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism of lipids and lipoproteins—APOE—Alzheimer's disease	1.13e-05	3.96e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—Alzheimer's disease	1.12e-05	3.93e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—A2M—Alzheimer's disease	1.11e-05	3.87e-05	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—BCHE—Alzheimer's disease	1.09e-05	3.8e-05	CbGpPWpGaD
Glucosamine—IFNG—Immune System—AKT1—Alzheimer's disease	1.08e-05	3.77e-05	CbGpPWpGaD
Glucosamine—TNF—Developmental Biology—IL6—Alzheimer's disease	1.05e-05	3.69e-05	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—PLCB1—Alzheimer's disease	1.03e-05	3.59e-05	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—ABCA1—Alzheimer's disease	9.94e-06	3.48e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—Alzheimer's disease	9.87e-06	3.45e-05	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—CASP3—Alzheimer's disease	9.75e-06	3.41e-05	CbGpPWpGaD
Glucosamine—TNF—Developmental Biology—AKT1—Alzheimer's disease	9.72e-06	3.4e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—ACHE—Alzheimer's disease	9.62e-06	3.37e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—INPP5D—Alzheimer's disease	9.51e-06	3.33e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—ENO1—Alzheimer's disease	9.02e-06	3.16e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—PTGS1—Alzheimer's disease	9.02e-06	3.16e-05	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—MAPK8—Alzheimer's disease	8.96e-06	3.14e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—CYP2D6—Alzheimer's disease	8.84e-06	3.1e-05	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—PPARGC1A—Alzheimer's disease	8.57e-06	3e-05	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—HMOX1—Alzheimer's disease	8.53e-06	2.99e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—BCHE—Alzheimer's disease	8.38e-06	2.94e-05	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—VEGFA—Alzheimer's disease	8.28e-06	2.9e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—PLCB1—Alzheimer's disease	7.91e-06	2.77e-05	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—LPL—Alzheimer's disease	7.8e-06	2.73e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	7.76e-06	2.72e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—ABCA1—Alzheimer's disease	7.67e-06	2.68e-05	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—TGFB1—Alzheimer's disease	7.6e-06	2.66e-05	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—MTHFR—Alzheimer's disease	7.02e-06	2.46e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—PPARGC1A—Alzheimer's disease	6.61e-06	2.31e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—HMOX1—Alzheimer's disease	6.58e-06	2.3e-05	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—CALM1—Alzheimer's disease	6.56e-06	2.3e-05	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—APOE—Alzheimer's disease	6.54e-06	2.29e-05	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—CAV1—Alzheimer's disease	6.48e-06	2.27e-05	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—TP53—Alzheimer's disease	6.25e-06	2.19e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—LPL—Alzheimer's disease	6.02e-06	2.11e-05	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—IL6—Alzheimer's disease	5.72e-06	2e-05	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—PPARG—Alzheimer's disease	5.69e-06	1.99e-05	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—INS—Alzheimer's disease	5.59e-06	1.96e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—MTHFR—Alzheimer's disease	5.42e-06	1.9e-05	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—AKT1—Alzheimer's disease	5.28e-06	1.85e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—CALM1—Alzheimer's disease	5.06e-06	1.77e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—APOE—Alzheimer's disease	5.04e-06	1.77e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—CAV1—Alzheimer's disease	5e-06	1.75e-05	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—NOS3—Alzheimer's disease	4.9e-06	1.71e-05	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—PTGS2—Alzheimer's disease	4.48e-06	1.57e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—PPARG—Alzheimer's disease	4.39e-06	1.54e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—INS—Alzheimer's disease	4.31e-06	1.51e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—NOS3—Alzheimer's disease	3.78e-06	1.32e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—PTGS2—Alzheimer's disease	3.46e-06	1.21e-05	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—AKT1—Alzheimer's disease	2.25e-06	7.88e-06	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—AKT1—Alzheimer's disease	1.74e-06	6.08e-06	CbGpPWpGaD
